{"disease":{"id":"differentiated-thyroid-cancer-dtc","name":"differentiated thyroid cancer dtc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07229859","title":"Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening","phase":"","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT04940052","title":"Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":153,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT02966093","title":"A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT02432274","title":"Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Eisai Limited","has_results":true},{"nct_id":"NCT06970353","title":"Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07536412","title":"Decision Aid Efficacy in Low Risk Thyroid Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":34,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT06855680","title":"The EMIRATES Study","phase":"","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Royal Marsden NHS Foundation Trust","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}